Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446402 · ClinicalTrials.gov registry record · Phase 4
Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT05446402: Completed Phase 4 study, sponsored by Northwestern University.
NCT05446402 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 29 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05446402, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.
Primary Outcome
Investigator Global Assessment (IGA) will be collected on a scale of 0-4 with 0 being clear and 4 being severe.
Interventions
- COMBINATION_PRODUCT Geologie Acne Regimen - one side of face
- COMBINATION_PRODUCT Proactive Acne Regimen - other side of face
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 4 |
What the finished NCT05446402 record still lists
NCT05446402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Geologie Acne Regimen - one side of face is the first listed.
NCT05446402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05446402 about?
NCT05446402 is a clinical study titled "Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne". The objective of this study is to compare tolerability of two similar commercially available over the counter acne regimens (Geologie and Proactiv) in individuals with mild to moderate acne vulgaris over a 12-week daily treatment course.
What is the current status of trial NCT05446402?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2022-06-15. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05446402?
The interventions under investigation include: Geologie Acne Regimen - one side of face (COMBINATION_PRODUCT), Proactive Acne Regimen - other side of face (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05446402?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05446402's enrollment target sits among peer trials
29 1634th of 2000 higher than 366 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI